Medicinal Chemistry, SAR, and Molecular Insights Into 2,4‐Thiazolidinediones as Antidiabetic Agents (2020–2025)
Archiv der Pharmazie · 2025-09 · 358 (9)
DOI: 10.1002/ardp.70102 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, online erschienen am 22.09.2025. Verfasst von Neeru Malik und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Maharaja Agrasen University, Baddi, Himachal Pradesh, India. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Thiazolidinediones, Diabetes Mellitus. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 133 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
The thiazolidinedione (TZD) scaffold has long been recognized for its pharmacological versatility, particularly in the treatment of metabolic and inflammatory disorders. Among its derivatives, 2,4‐thiazolidinediones (2,4‐TZDs) have emerged as a prominent class of antidiabetic agents with diverse molecular targets. While their role as peroxisome proliferator‐activated receptor gamma (PPAR‐γ) agonists is well established, recent studies have revealed additional therapeutic mechanisms, including inhibition of protein tyrosine phosphatase 1B (PTP‐1B), α‐amylase, α‐glucosidase, and aldose reductase—each contributing to improved glucose regulation and diabetes management. Moreover, the rise of dual and multitarget inhibitors highlights the evolving therapeutic potential of 2,4‐TZDs beyond conventional pathways. This review presents a comprehensive analysis of recent developments (2020–2025) in the medicinal chemistry, structure–activity relationships (SARs), and antidiabetic mechanisms of 2,4‐TZDs. Key structural modifications and their influence on biological activity are critically evaluated, alongside updates on recent patent disclosures and ongoing clinical trials. By integrating medicinal chemistry insights with pharmacological data, this review aims to support the rational design of next‐generation 2,4‐TZD‐based antidiabetic therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Maharaja Agrasen University, Baddi, Himachal Pradesh, India.
- Faculty of Pharmacy, I.K. Gujral Punjab Technical University, Jalandhar, India.
- Department of Pharmaceutical Chemistry, Shivalik College of Pharmacy, Nangal, Punjab, India.
ORCID-Profile: Neeru Malik, Rajesh Kumar Singh
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Malik, N., & Singh, R. K. (2025). Medicinal Chemistry, SAR, and Molecular Insights Into 2,4‐Thiazolidinediones as Antidiabetic Agents (2020–2025). Archiv der Pharmazie, 358(9). https://doi.org/10.1002/ardp.70102
Vancouver
Malik N, Singh RK. Medicinal Chemistry, SAR, and Molecular Insights Into 2,4‐Thiazolidinediones as Antidiabetic Agents (2020–2025). Archiv der Pharmazie. 2025;358(9). doi:10.1002/ardp.70102
BibTeX
@article{Malik2025,
author = {Malik, Neeru and Singh, Rajesh Kumar},
title = {Medicinal Chemistry, SAR, and Molecular Insights Into 2,4‐Thiazolidinediones as Antidiabetic Agents (2020–2025)},
journal = {Archiv der Pharmazie},
year = {2025},
volume = {358},
number = {9},
doi = {10.1002/ardp.70102}
}
EUVIMED